Obesity and chronic kidney disease
- Authors: Bondar' I.A.1, Klimontov V.V.1, Simakova AI1, Bondar IA2, Klimontov VV2, Simakova AI2
-
Affiliations:
- ГОУ ВПО Новосибирский государственный медицинский университет
- State Medical University, Novosibirsk
- Issue: Vol 83, No 6 (2011)
- Pages: 66-70
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/30884
- ID: 30884
Cite item
Full Text
Abstract
Keywords
About the authors
Irina Arkad'evna Bondar'
ГОУ ВПО Новосибирский государственный медицинский университет
Email: diabet@oblmed.nsk.ru
каф. эндокринологии; ГОУ ВПО Новосибирский государственный медицинский университет
Vadim Vladimirovich Klimontov
ГОУ ВПО Новосибирский государственный медицинский университет
Email: klimontov@mail.ru
д-р мед. наук, доц., каф. эндокринологии; ГОУ ВПО Новосибирский государственный медицинский университет
A I Simakova
ГОУ ВПО Новосибирский государственный медицинский университетГОУ ВПО Новосибирский государственный медицинский университет
I A Bondar
State Medical University, NovosibirskState Medical University, Novosibirsk
V V Klimontov
State Medical University, NovosibirskState Medical University, Novosibirsk
A I Simakova
State Medical University, NovosibirskState Medical University, Novosibirsk
References
- Дедов И. И., Мельниченко Г. А. (ред.). Ожирение. М.: Мед. информ. агентство; 2004.
- Hunley T. E., Ma L. J., Kon V. Scope and mechanisms of obesity-related renal diseasec Curr. Opin. Nephrol. Hypertens. 2010; 19 (3): 227-234.
- Федорова Е. Ю., Краснова Е. А., Шестакова М. В. Механизмы повреждения почек при ожирении. Ожирение и метаболизм 2006; 1: 22-28.
- Gelber R. P., Kurth T., Kausz A. T. et al. Association between body mass index and CKD in apparently healthy men. Am. J. Kidney Dis. 2005; 46 (5): 871-880.
- Ishizaka Y., Ishizaka N., Tani M. et al. Association between changes in obesity parameters and incidence of chronic kidney disease in Japanese individuals. Kidney Blood Press. Res. 2009; 32 (2): 141-149.
- Ryu S., Chang Y., Woo H. Y. Changes in body weight predict CKD in healthy men. J. Am. Soc. Nephrol. 2008; 19 (9): 1798-1805.
- Foster M. C., Hwang S. J., Larson M. G. et al. Association between body mass index and chronic kidney disease: a population-based, cross-sectional study of a Japanese community. Vasc. Hlth Risk Manag. 2009; 5 (1): 315-320.
- Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am. J. Kidney Dis. 2008; 52 (1): 39-48.
- Kramer H., Luke A., Bidani A. et al. Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program. Am. J. Kidney Dis. 2005; 46 (4): 587-594.
- Munkhaugen J., Lydersen S., Wideré T. E., Hallan S. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Am. J. Kidney Dis. 2009; 54 (4): 638-646.
- Chen J., Muntner P., Hamm L. L. et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann. Intern. Med. 2004; 140 (3): 167-174.
- Chen J., Gu D., Chen C. S. et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol. Dial. Transplant. 2007; 22 (4): 1100-1106.
- Noori N., Hosseinpanah F., Nasiri A. A., Azizi F. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J. Ren. Nutr. 2009; 19 (3): 228-237.
- Tanaka M., Yamada S., Iwasaki Y. et al. Impact of obesity on IgA nephropathy: comparative ultrastructural study between obese and non-obese patients. Nephron. Clin. Pract. 2009; 112 (2): c71-c78.
- Bonnet F., Deprele C., Sassolas A. et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am. J. Kidney Dis. 2001; 37 (4): 720-727.
- Lee M. N., Shaikh U., Butani L. Effect of overweight/obesity on recovery after post-infectious glomerulonephritis. Clin. Nephrol. 2009; 71 (6): 632-636.
- Савельева С. А., Крячкова А. А., Курумова К. О. и др. Ожирение-фактор риска поражения почек у больных сахарным диабетом 2-го типа. Сахар. диабет 2010; 2: 45-49.
- Othman M., Kawar B., El Nahas A. M. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron. Clin. Pract. 2009; 113 (1): c16-c23.
- Postorino M., Marino C., Tripepi G. et al. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J. Am. Coll. Cardiol. 2009; 53 (15): 1265-1272.
- Chow W. H., Devesa S. S. Contemporary epidemiology of renal cell cancer. Cancer J. 2008; 14 (5): 288-301.
- Klinghoffer Z., Yang B., Kapoor A., Pinthus J. H. Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert. Rev. Anticancer. Ther. 2009; 9 (7): 975-987.
- Srivastava T. Nondiabetic consequences of obesity on kidney. Pediatr. Nephrol. 2006; 21 (4): 463-470.
- Kambham N., Markowitz G. S., Valeri A. M. et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001; 59 (4): 1498-1509.
- Adelman R. D., Restaino I. G., Alon U. S., Blowey D. L. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J. Pediatr. 2001; 138 (4): 481-485.
- Serra A., Romero R., Lopez D. et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008; 73 (8): 947-955.
- Goumenos D. S., Kawar B., El Nahas M. et al. Early histological changes in the kidney of people with morbid obesity. Nephrol. Dial. Transplant. 2009; 24 (12): 3732-3738.
- Chen H. M., Li S. J., Chen H. P. et al. Obesity-related glomerulopathy in China: a case series of 90 patients. Am. J. Kidney Dis. 2008; 52 (1): 58-65.
- Chen H. M., Liu Z. H., Zeng C. H. et al. Podocyte lesions in patients with obesity-related glomerulopathy. Am. J. Kidney Dis. 2006; 48 (5): 772-779.
- Verhave J. C., Fesler P., Ribstein J. et al. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am. J. Kidney Dis. 2005; 46 (2): 233-241.
- Demirovic J. A., Pai A. B., Pai M. P. Estimation of creatinine clearance in morbidly obese patients. Am. J. Hlth Syst. Pharm. 2009; 66 (7): 642-648.
- Сагинова Е. А., Галямов Н. Г., Северова Н. Н. Современные представления о поражении почек при ожирении. Клин. нефрол. 2010; 2: 66-71.
- Руденко Т. Е., Кутырина И. М. Ожирение как фактор сосудистого ремоделирования. Клин. нефрол. 2010; 3: 62-67.
- Ritz E., Kolgeganova T., Piecha G. Is there an obesity-metabolic syndrome related glomerulopathy? Curr. Opin. Nephrol. Hypertens. 2010; In press.
- Galic S., Oakhill J. S., Steinberg G. R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010; 316 (2): 129-139.
- Zhang Y., Scarpace P. J. The role of leptin in leptin resistance and obesity. Physiol. Behav. 2006; 88 (3): 249-256.
- Nanayakkara P. W., Le Poole C. Y., Fouque D. et al. Plasma adi-ponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3-5 chronic kidney disease. Clin. Nephrol. 2009; 72 (1): 21-30.
- Wolf G., Ziyadeh F. N. Leptin and renal fibrosis. Contrib. Nephrol. 2006; 151: 175-183.
- Wu Y., Liu Z., Xiang Z. et al. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006; 147 (1): 44-50.
- Sharma K., Ramachandrarao S., Qiu G. et al. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 2008; 118 (5): 1645-1656.
- Ohashi K., Iwatani H., Kihara S. et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler. Thromb. Vase. Biol. 2007; 27 (9): 1910-1917.
- Praga M., Morales E. Obesity, proteinuria and progression of renal failure. Curr. Opin. Nephrol. Hypertens. 2006; 15 (5): 481-486.
- Chalmers L., Kaskel F. J., Bamgbola O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv. Chron. Kidney Dis. 2006; 13 (4): 352-364.
- Кутырина И. М., Крячкова А. А., Савельева С. А., Шестакова М. В. Роль альдостерона в поражении почек при метаболическом синдроме, ассоциированном с ожирением. Клин, нефрол. 2010; 4: 34-38.
- Шварц В. Воспаление жировой ткани. Часть 1. Морфологические и функциональные проявления. Пробл. эндокринол. 2009; 4: 44-49.
- Шварц В. Воспаление жировой ткани. Часть 3. Патогенетическая роль в развитии атеросклероза. Пробл. эндокринол. 2009; 6: 40-45.
- Teplan V. Jr., Vyhnänek F., Gürlich R. et al. Increased proinflamma-tory cytokine production in adipose tissue of obese patients with chronic kidney disease. Wien. Klin. Wschr. 2010; 122 (15-16): 466-473.
- Ramos L. F., Shintani A., Ikizler T. A., Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J. Am. Soc. Nephrol. 2008; 19 (3): 593-599.
- Elmarakby A. A., Imig J. D. Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clin. Sci. (Lond.) 2010; 118 (4): 291-301.
- Мухин Н. А., Фомин В. В., Сагинова Е. А. и др. Эндотелиальная дисфункция и поражение почек при ожирении. Вестн. РАМН 2006; 12: 25-31.
- Сагинова Е. А., Федорова Е. Ю., Фомин В. В. и др. Формирование поражения почек у больных ожирением. Тер. арх. 2006; 5: 36-41.
- Deji N., Kume S., Araki S. et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J. Physiol. Renal Physiol. 2009; 296 (1): F118-F126.
- Jiang T., Wang Z., Proctor G. et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol, Chem. 2005; 280 (37): 32317-32325.
- Bosma R. J., Krikken J. A., Homan van der Heide J. J. et al. Obesity and renal hemodynamics. Contrib. Nephrol. 2006; 151: 184-202.
- Кутырина И. М., Федорова Е. Ю., Шестакова М. В. Ожирение и почки. В кн.: Сахарный диабет и хроническая болезнь почек. М.: Мед. информ. Агентство; 2009. 415-428.
- Praga M., Hernandez E., Herrero J. C. et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000; 58 (5): 2111-2118.
- Gonzalez E., Gutierrez E., Morales E. et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int. 2005; 68 (1): 263-270.
- Navaneethan S. D., Yehnert H., Moustarah F. et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 2009; 4 (10): 1565-1574.
- Ishizaka Y., Ishizaka N., Tani M. et al. Association between changes in obesity parameters and incidence of chronic kidney disease in Japanese individuals. Kidney Blood Press. Res. 2009; 32 (2): 141-149.
- Shen W. W., Chen H. M., Chen H. et al. Obesity-related glomerulopa-thy: body mass index and proteinuria. Clin. J. Am. Soc. Nephrol. 2010; 5 (8): 1401-1409.
- Chagnac A., WeinsteinT., Herman M. et al. The effects of weight loss on renal function in patients with severe obesity. J. Am. Soc. Nephrol. 2003; 14 (6): 1480-1486.
- Navarro-Diaz M., Serra A., Romero R. et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J. Am. Soc. Nephrol. 2006; 17 (12, Suppl. 3): S213-S217.
- Serpa Neto A., Bianco Rossi F. M., Dal Moro Amarante R. et al. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients. J. Nephrol. 2009; 22 (5): 637-646.
- Huan Y., Tomaszewski J. E., Cohen D. L. Resolution of nephrotic syndrome after successful bariatric surgery in patient with biopsy-proven FSGS. Clin. Nephrol. 2009; 71 (1): 69-73.
- Недогора С. В. Возможности нефропротекции у пациентов с метаболическим синдромом. Клин. нефрол. 2009; 2: 26-30.